News

When Edwards was a guest on this week’s episode of the Filmmaker Toolkit podcast, he discussed how the hardest aspect of the ...
New PICCOLO trial analyses showed that mirvetuximab soravtansine achieved 52% response rates and 27-month overall survival in ...